The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

EORTC CLTF 2018 | Insight into CTCL intratumor heterogeneity may inform disease management

Name: Insight into CTCL intratumor heterogeneity may inform disease management
Uploaded: 2018-09-27T00:00:00.000Z
Duration: 1 min 25 s
Description: Robert Gniadecki, MD, PhD, of the University of Alberta, Edmonton, Canada, explores how mutation distribution in cutaneous T-cell lymphoma translates into clinically significant data. This video was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.

Robert Gniadecki • 27 Sep 2018

EORTC CLTF 2018

Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases T-Cell Lymphoma

Robert Gniadecki, MD, PhD, of the University of Alberta, Edmonton, Canada, explores how mutation distribution in cutaneous T-cell lymphoma translates into clinically significant data. This video was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.